Ahmedabad-headquartered Torrent Pharmaceuticals said on Thursday that the company has completed acquisition of branded businesses of Unichem Laboratories Limited for India and Nepal, including its Sikkim manufacturing facility, on a going concern basis by way of slump sale.
The two companies had entered into a definitive binding agreement on November 3, 2017 for the same. The deal is valued at Rs 3,600 crore.
"From today, Torrent begins the integration of the Unichem business following the successful closure of its acquisition. The integration will aim to fuel and support strong growth of the acquired Unichem brands, consolidating speciality reach with a